| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Regenxbio Inc. (RGNX) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. RGNX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 495.9K | $5.52M | - | |
| CEO | 338.1K | $3.77M | - | |
| Other | 215.4K | $2.40M | - | |
| Other | 64.8K | $722.0K | - | |
| CFO | 39.6K | $441.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 5, 2020 | Vasista Vittal79 | Chief Financial Officer | Sell | 300 | $50.00 | $15,000.00 | -0.1% | |
| Feb 5, 2020 | Simpson Curran66 | SVP, Product Development &CTO | Sale+OE | 5,637 | $50.00 | $281,850.00 | -19.9% | |
| Feb 5, 2020 | Hayden Donald J Jr | Director | Sale+OE | 2,000 | $50.00 | $100,000.00 | -100% | |
| Jan 17, 2020 | Simpson Curran66 | SVP, Product Development &CTO | Sale+OE | 5,922 | $50.00 | $296,100.00 | -20.4% | |
| Jan 17, 2020 | Vasista Vittal79 | Chief Financial Officer | Sell | 2,394 | $50.00 | $119,700.00 | -1.1% | |
| Jan 17, 2020 | Hayden Donald J Jr | Director | Sale+OE | 3,200 | $50.01 | $160,032.00 | -100% | |
| Jan 14, 2020 | Hayden Donald J Jr | Director | Sale+OE | 30,000 | $45.60 | $1,368,000.00 | -100% | |
| Jan 8, 2020 | Vasista Vittal79 | Chief Financial Officer | Sale+OE | 7,500 | $41.75 | $313,152.00 | -1.6% | |
| Dec 9, 2019 | Simpson Curran66 | SVP, Product Development &CTO | Sell | 15,552 | $43.74 | $680,248.38 | -22.3% | |
| Sep 19, 2019 | Mills Kenneth T.81 | President And CEO | Sale+OE | 10,000 | $39.75 | $397,496.56 | -2.0% |